Nektar Therapeutics
NKTR
#5687
Rank
$1.15 B
Marketcap
$56.90
Share price
-1.37%
Change (1 day)
271.90%
Change (1 year)

Nektar Therapeutics (NKTR) - Cash on Hand

Cash on Hand as of September 2025 : $0.27 Billion USD

According to Nektar Therapeutics 's latest financial reports the company has $0.27 Billion USD in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Nektar Therapeutics - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31$0.25 B-15.94%
2023-12-31$0.30 B-39.88%
2022-12-31$0.50 B-31.2%
2021-12-31$0.73 B-30.88%
2020-12-31$1.06 B-19.85%
2019-12-31$1.32 B-0.79%
2018-12-31$1.33 B350.93%
2017-12-31$0.29 B-23.89%
2016-12-31$0.38 B25.95%
2015-12-31$0.30 B29.9%
2014-12-31$0.23 B0.34%
2013-12-31$0.23 B-14.49%
2012-12-31$0.27 B14.94%
2011-12-31$0.24 B-23.66%
2010-12-31$0.31 B-20.26%
2009-12-31$0.39 B4.54%
2008-12-31$0.37 B-21.43%
2007-12-31$0.48 B5.17%
2006-12-31$0.45 B-3.69%
2005-12-31$0.47 B13.72%
2004-12-31$0.41 B46.43%
2003-12-31$0.28 B-2.72%
2002-12-31$0.29 B-14.63%
2001-12-31$0.34 B-28.98%
2000-12-31$0.48 B250.86%
1999-12-31$0.13 B66.77%
1998-12-31$82.86 M-17.28%
1997-12-31$0.10 B438.56%
1996-12-31$18.6 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Amgen
AMGN
$9.44 B 3,395.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
$14.98 B 5,445.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$18.21 B 6,640.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Richardson Electronics
RELL
$35.65 M-86.80%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
$8.18 B 2,928.04%๐Ÿ‡ฌ๐Ÿ‡ง UK
Baxter
BAX
$1.72 B 538.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
$1.11 B 311.21%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Johnson & Johnson
JNJ
$18.56 B 6,769.52%๐Ÿ‡บ๐Ÿ‡ธ USA